MedPath
HSA Approval

PANSIPTIN FILM COATED TABLETS 50MG

SIN17193P

PANSIPTIN FILM COATED TABLETS 50MG

PANSIPTIN FILM COATED TABLETS 50MG

March 4, 2025

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

A10BH01

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

SAG MANUFACTURING, S.L.U.

Active Ingredients

Sitagliptin HCl monohydrate eqv Sitagliptin

50.00mg

Sitagliptin

Documents

Package Inserts

PANSIPTIN Film Coated Tablet PI.pdf

Approved: March 4, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.